Forecast & Rating4 analysts currently cover CSTONE PHARMA-B, of which 4 give a positive rating. The average price target is HK$14.43, about 150.2% upside from the current price of HK$5.77. Coverage is limited, so the data is for reference only. Data as of Sep 1, 2026; this does not constitute investment advice.
Aug 31, 2026Price forecast
HK$14.43150.24%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 30, 2026
Forecast met34.9%
Stock price$5.77
Avg. target$13.3
High target$20
Low target$7
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.